1/ Quick update on those risk/reward numbers from JCVI's statement on children 12-15 that have caused so much Twitter controversy. I've got an answer... of sorts...
2/ The controversy revolves round these two tables from the JCVI statement. Table 4 shows estimated number of myocarditis cases resulting from vax. These are in line with US estimates and not controversial.
3/ It's table 3 that's the problem - the number of nasty outcomes caused by Covid and prevented by vaccination.
Members of iSage say JCVI has got its these wrong by a factor of 6. A simple but fundamental "error" has been made - allegedly
4/ The error, they say, is that JCVI uses a fixed population denominator, rather than cases, as used in this alternative analysis by @dgurdasani1 et al osf.io/grzma/
The result, they say, is JCVI under plays the impact of Covid on kids and the benefit of vaccination
5/ But I asked the JCVI and they say this is NOT the case. "The JCVI used infection based denominators from modelling and seroprevalence (not fixed populations) to estimate risk per infection", it says
6/ It's analysis is dynamic, reflecting the ebb and flow of the pandemic. It then hits back and says the case (as opposed to infection) based approach used in the paper above is itself flawed, inflating the benefit of vax to kids. It gives these 3 reasons:
7/ i/ It underestimates the denominator infected, so overestimates the risk per infection
ii/ It doesn't account for children who have already been infected and have less to gain from vaccination
iii/ It doesn’t split out high risk kids, so overestimates benefits to the healthy
8/ I asked the JCVI for full written details. They said they could not provide now but a full paper covering its methods and calculations would be published soon.
9/ And the lessons from all this?
🧨Publish your workings in full to stop misinformation circulating
🧨 Don't accuse others of errors or malfeasance until you are SURE about what they've done
1/5 The Royal Soc of Paediatrics and Child Health seems lukewarm at best on Covid vax for kids.
It says it could benefit healthy children “irrespective of any direct health benefit" but only if part of a "concerted overall plan" to keep schools open.
2/ I then adds: “It is extremely important that any COVID-19 vaccination programme in schools does not interfere in any way with other school vaccination programmes where the health benefits are more clear-cut".
3/ Also, if vaccinations are offered, children and families must receive "clear and non-judgemental advice about the risks as well as the benefits".
“We would be against any plans to make vaccination mandatory", it notes.
1/5 Great work by @JamesWard73 but troubling given that over 6,000 PEOPLE have died since the 3rd wave started in mid May and things are clearly not over yet..
2/ I had not realised quite how critical the timing of booster jabs might be, something that is going to be logistically tricky for an overstretched NHS. Also, the winter looks long...
3/ The impact changes in behaviour make are more predictable but vital for policymakers to grasp. Comix is still showing UK contacts at less than half pre pandemic levels...
Anthony Fauci, Director of the U.S. National Institute of Allergy and Infectious Diseases (NIAID), believes a third shot of vaccine should be seen, not as a ‘booster’, but part of the standard regimen for Covid-19 vaccination....
2/ Delivering The John Snow Society Annual Pumphandle Lecture, he noted that several other vaccines, including the jab for Hepatitis B, required a third dose as part of their standard regimen and said he thought the evidence suggested Covid-19 vaccines would require the same...
3/“The real question we are struggling with ... is [this]: is the booster shot a boost for a vaccine regimen with waning efficacy or should the booster shot be part of the original vaccine regimen? And I must tell you I favour very strongly the latter”.
1/ Important briefing from #Covax today on vaccinating the not-so-rich bits of the world (most of it). There is good and bad news....
2/ Because I'm a journo, let's start with the bad: Covax expects to get about 25% LESS vaccine in by the end of the year than initially forecast. That's a shortfall of 440m doses.
3/ It should be noted that the main reasons for this are technical rather than nefarious - the devastating 2nd wave in India, production difficulties, regulatory hurdles...